Wermatswil, Switzerland

Nihad Hasagic

USPTO Granted Patents = 1 


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nihad Hasagic: Innovator in Pathology Laboratory Workflow Analysis

Introduction

Nihad Hasagic is a notable inventor based in Wermatswil, Switzerland. He has made significant contributions to the field of pathology through his innovative patent that focuses on analyzing workflow in pathology laboratories. His work aims to enhance the efficiency and effectiveness of specimen processing.

Latest Patents

Nihad Hasagic holds a patent titled "Systems and methods for analyzing workflow associated with a pathology laboratory." This invention involves a computer system designed to analyze a specimen processing workflow in a pathology laboratory. The system includes a display and a processor that provides multiple interfaces to receive parameters related to existing and proposed workflows. It determines current performance data, cost information, and time utilization, allowing for a comprehensive comparison of revised performance data against current metrics.

Career Highlights

Nihad Hasagic is currently employed at Dako Denmark A/S, where he applies his expertise in workflow analysis to improve laboratory processes. His innovative approach has the potential to transform how pathology laboratories operate, leading to better resource management and improved patient outcomes.

Collaborations

Nihad has collaborated with notable colleagues such as Flemming Juncker and Mats Grahn. Their combined efforts contribute to advancing the field of pathology and enhancing laboratory efficiency.

Conclusion

Nihad Hasagic's work in developing systems for analyzing pathology laboratory workflows showcases his commitment to innovation in healthcare. His contributions are paving the way for more efficient laboratory practices, ultimately benefiting the medical community and patients alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…